Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells

Autonomic Neuroscience: Basic and Clinical

Volumn 110, Issue 1, 2004, Pages 36-43

  Nakagawa, Atsushi ^a   Satake, Hanae ^a   Nakabayashi, Hajime ^b   Nishizawa, Makoto ^a   Furuya, Keisuke ^a   Nakano, Shigeru ^a   Kigoshi, Toshikazu ^a   Nakayama, Kohzo ^c   Uchida, Kenzo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene expression; Glucagon like peptide 1 receptor; Glucose dependent insulinotropic polypeptide receptor; Incretin; Nodose ganglion

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMORECEPTOR; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN SITU HYBRIDIZATION; MALE; NERVE CELL; NODOSE GANGLION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; QUANTITATIVE GENETICS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VAGUS NERVE STIMULATION;

EID: 0842325280     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2003.11.001     Document Type: Article

References (45)

1. Alvarez E., Roncero I., Chowen J.A., Thorens B., Blázquez E. Expression of the glucagon-like peptide-1 receptor gene in rat brain. J. Neurochem. 66:1996;920-927.
2. Balkan B., Li X. Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am. J. Physiol., Regul. Integr. Comp. Physiol. 279:2000;R1449-R1454.
3. Berthoud H.-R., Patterson L.M. Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat. 156:1996;123-131.
4. Broberger C., Holmberg K., Shi T.-J., Dockray G., Hökfelt T. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia. Brain Res. 903:2001;128-140.
5. Bullock B.P., Heller R.S., Habener J.F. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology. 137:1996;2968-2978.
6. Burdyga G., Spiller D., Morris R., Lal S., Thompson D.G., Saeed S., Dimaline R., Varro A., Dockray G.J. Expression of the leptin receptor in rat and human nodose ganglion neurones. Neuroscience. 109:2002;339-347.
7. Burdyga G., Lal S., Spiller D., Jiang W., Thompson D., Attwood S., Saeed S., Grundy D., Varro A., Dimaline R., Dockray G.J. Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans. Gastroenterology. 124:2003;129-139.
8. Buyse M., Ovesjö M.-L., Goïot H., Guilmeau S., Péranzi G., Moizo L., Walker F., Lewin M.J.M., Meister B., Bado A. Expression and regulation of leptin receptor proteins in afferent and efferent neurons of the vagus nerve. Eur. J. Neurosci. 14:2001;64-72.
9. Cooper E. Synapse formation among developing sensory neurones from rat nodose ganglia grown in tissue culture. J. Physiol. 351:1984;263-274.
10. Creutzfeldt W. The entero-insular axis in type 2 diabetes-incretins as therapeutic agents. Exp. Clin. Endocrinol. Diabetes. 109(Suppl. 2):2001;S288-S303.
11. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., Kangawa K., Nakazato M. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology. 123:2002;1120-1128.
12. Deacon C.F., Pridal L., Klarskov L., Olesen M., Holst J.J. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am. J. Physiol. 271:1996;E458-E464.
13. Drucker D.J. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. Curr. Pharm. Des. 7:2001;1399-1412.
14. Esclapez M., Tillakaratne N.J.K., Kaufman D.L., Tobin A.J., Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J. Neurosci. 14:1994;1834-1855.
15. Göke R., Fehmann H.-C., Linn T., Schmidt H., Krause M., Eng J., Göke B. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells. J. Biol. Chem. 268:1993;19650-19655.
16. Gotoh M., Maki T., Kiyoizumi T., Satomi S., Monaco A.P. An improved method for isolation of mouse pancreatic islets. Transplantation. 40:1985;437-438.
17. Hansen L., Deacon C.F., Ørskov C., Holst J.J. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology. 140:1999;5356-5363.
18. Holst J.J., Ørskov C., Vagn Nielsen O., Schwartz T.W. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett. 211:1987;169-174.
19. İmeryüz N., Yegen B.Ç., Bozkurt A., Coşkun T., Villanueva-Peñacarrillo M.L., Ulusoy N.B. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol. 273:1997;G920-G927.
20. 2+ in rat nodose ganglion neurons. Auton. Neurosci. 102:2002;39-44.
21. Lamari Y., Boissard C., Moukhtar M.S., Jullienne A., Rosselin G., Garel J.-M. Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1. FEBS Lett. 393:1996;248-252.
22. Meier J.J., Gallwitz B., Nauck M.A. Glucagon-like peptide 1 and gastric inhibitory polypeptide. Potential applications in type 2 diabetes mellitus. BioDrugs. 17:2003;93-102.
23. B receptors expressed by vagal afferent neurons. Neuroscience. 79:1997;905-913.
24. Nakabayashi H., Niijima A., Kurata Y., Usukura N., Takeda R. Somatostatin-sensitive neural system in the liver. Neurosci. Lett. 67:1986;78-81.
25. Nakabayashi H., Niijima A., Kurata Y., Jiang Z.-Y., Usukura N., Takeda R. Pancreatic vagal nerve is receptive to somatostatin in rats. Am. J. Physiol. 253:1987;R200-R203.
26. Nakabayashi H., Niijima A., Nishizawa M., Nakabayashi I.O., Takeda R. A unique receptor-mediated mechanism in vagal chemoreception of somatostatin in the hepatoportal area. J. Auton. Nerv. Syst. 50:1994;45-50.
27. Nakabayashi H., Kobayashi K., Nakabayashi I.O., Kurata Y. Somatostatin receptor on the afferent nerve terminals in the rat hepatoportal area. Neurosci. Lett. 183:1995;46-49.
28. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearnace of tGLP-1. Am. J. Physiol. 271:1996;E808-E813.
29. Nakayama K., Pattanakitsakul S., Yokoyama S., Kimura H., Nonaka M., Takahashi M. Post-transcriptional regulation of complement C4 in low C4-producing strain of mouse. Immunogenetics. 31:1990;361-367.
30. Nishizawa M., Nakabayashi H., Uchida K., Nakagawa A., Niijima A. The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. J. Auton. Nerv. Syst. 61:1996;149-154.
31. Nishizawa M., Nakabayashi H., Kawai K., Ito T., Kawakami S., Nakagawa A., Niijima A., Uchida K. The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP1 receptor. J. Auton. Nerv. Syst. 80:2000;14-21.
32. Norgren R., Smith G.P. Central distribution of subdiaphragmatic vagal branches in the rat. J. Comp. Neurol. 273:1988;207-223.
33. Peiser C., Springer J., Gronegerg D.A., McGregor G.P., Fischer A., Lang R.E. Leptin receptor expression in nodose ganglion cells projecting to the rat gastric fundus. Neurosci. Lett. 320:2002;41-44.
34. Sakata I., Yamazaki M., Inoue K., Hayashi Y., Kangawa K., Sakai T. Growth hormone secretagogue receptor expression in the cells of the stomach-projected afferent nerve in the rat nodose ganglion. Neurosci. Lett. 342:2003;183-186.
35. Schmidt W.E., Siegel E.G., Creutzfeldt W. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia. 28:1985;704-707.
36. Schwartz G.J. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition. 16:2000;866-873.
37. Swift G.H., Peyton M.J., MacDonald R.J. Assessment of RNA quality by semi-quantitative RT-PCR of multiple regions of a long ubiquitous mRNA. BioTechniques. 28:2000;524-531.
38. Thorens B. Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. U. S. A. 89:1992;8641-8645.
39. Thorens B., Porret A., Bühler L., Deng S.-P., Morel P., Widmann C. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes. 42:1993;1678-1682.
40. Tian Q.B., Nakayama K., Okano A., Suzuki T. Identification of mRNAs localizing in the postsynaptic region. Mol. Brain Res. 72:1999;147-157.
41. 4-isomerase in the rat purkinje neuron during neonatal life. Endocrinology. 140:1999;805-813.
42. Usdin T.B., Mezey É., Button D.C., Brownstein M.J., Bonner T.I. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology. 133:1993;2861-2870.
43. Volz A., Göke R., Lankat-Buttgereit B., Fehmann H.-C., Bode H.P., Göke B. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. FEBS Lett. 373:1995;23-29.
44. Wettergren A., Wøjdemann M., Holst J.J. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am. J. Physiol. 275:1998;G984-G992.
45. Yip R.G.-C., Boylan M.O., Kieffer T.J., Wolfe M.M. Functional GIP receptors are present on adipocytes. Endocrinology. 139:1998;4004-4007.